Your browser doesn't support javascript.
loading
Sequential chromatin immunoprecipitation to detect SUMOylated MeCP2 in neurons.
Wu, Tao; Donohoe, Mary E.
Afiliação
  • Wu T; Burke Medical Research Institute, White Plains, NY 10605, U.S.A, Department of Neuroscience Brain Mind Research Institute, Department of Cell & Development, Weill Cornell Medical College, New York, NY 10065, U.S.A.
  • Donohoe ME; Burke Medical Research Institute, White Plains, NY 10605, U.S.A, Department of Neuroscience Brain Mind Research Institute, Department of Cell & Development, Weill Cornell Medical College, New York, NY 10065, U.S.A.
Biochem Biophys Rep ; 5: 374-378, 2016 Mar.
Article em En | MEDLINE | ID: mdl-28944302
The small ubiquitin-like modifier (SUMO) is a short peptide that can be covalently linked to proteins altering their function. SUMOylation is an essential post-translational modification (PTM). Because of its dynamic nature, low abundance levels, and technical limitations, the occupation of endogenous SUMOylated transcription factors at genomic loci is challenging to detect. The chromatin regulator Methyl CpG binding protein 2 (MeCP2) is subjected to PTMs including SUMO. Mutations in MeCP2 lead to Rett syndrome, a severe neurodevelopmental disorder. Here, we present an efficient method to perform sequential chromatin immunoprecipitation (Seq-ChIP) for detecting SUMOylated MeCP2 in neurons. This Seq-ChIP technique is a useful tool to determine the occupancy of SUMOylated transcription and chromatin factors at specific genomic regions.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biochem Biophys Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biochem Biophys Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos